Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions Q&A
About Purpose
- Q1 Why are transparency guidelines necessary?
- Q2 What is the purpose of the newspaper ad "What is the money paid by pharmaceutical companies to hospitals and doctors? What is the purpose of this ad? Also, what do you want to convey?
About information disclosure
- Q3 What do pharmaceutical companies pay to medical institutions and doctors?
- Q4 How can I see the information that has been released to the public?
- Q5 Why does the method of disclosure vary from company to company?
- Q6 How long has the information been publicly available? Can I go back and look at the information?
About implementing companies and their enforceability
- Q7 Do all pharmaceutical companies that are members of the Pharmaceutical Manufacturers Association of Japan (PMAJ) develop and publish transparency guidelines?
- Q8 Are the transparency guidelines enforceable and are there penalties for non-compliance?
Donations
Impact on Patients, Consumers, and Medical Professionals
- Q10 How do publicly disclosed payments to medical institutions and health care providers affect the price of drugs?
- Q11. Does the disclosed information ever fall under the category of personal information?
- Q12 Does the payment of money by pharmaceutical companies to medical professionals distort their activities and judgment?
About overseas cases
About each item to be disclosed
- Q14 What are research and development expenses, etc.?
- Q15 What are scholarship donations?
- Q16 What are academic conference donations?
- Q17 What are lecture honoraria, manuscript writing/supervision fees, consulting fees, and other outsourcing fees?
- Q18 What are lecture meeting expenses?
- Q19 What do you mean by "other expenses"?